re cap global investors ag - Company Review
re cap global investors ag - Company ReviewSummary
re:cap global investors ag (re:cap) is a consulting company that offers mergers and acquisitions advisory and asset management services to renewable energies. The company's mergers and acquisitions advisory services include strategy development, technical and legal due diligence, economic, negotiations, capital raising, sales and project selection services. It also provides advisory services for institutional investors on their investments in infrastructure projects. re:cap’s asset management services comprise process optimization, portfolio management, commercial management and reporting, and technical controlling services. The company’s partner portfolio includes Photovoltaik Institut Berlin, PVLab Germany, PWC, RSM Germany, Osborne Clarke and Norton Rose Fulbright among others. re:cap is headquartered in Zug, Switzerland.
This comprehensive company report of re cap global investors ag provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.